Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Public ClinicalTrials.gov record NCT00773734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Study identification
- NCT ID
- NCT00773734
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 352 participants
Conditions and interventions
Conditions
Interventions
- Apremilast 10mg Drug
- Apremilast 20mg Drug
- Apremilast 30 mg Drug
- Apremilast 30mg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2008
- Primary completion
- Jul 31, 2009
- Completion
- May 19, 2015
- Last update posted
- May 6, 2020
2008 – 2015
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Associates In Research Inc | Fresno | California | 93720 | — |
| Dermatology Associates | Los Angeles | California | 90045 | — |
| Stanford University School of Medicine | Redwood City | California | 94063 | — |
| Atlantic Skin & Cosmetic Surgery Group, PC | Wilmington | Delaware | 19810 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Atlanta Dermatology, Vein & Research Center | Alpharetta | Georgia | 30022 | — |
| NorthShore University HealthSystem | Skokie | Illinois | 60077 | — |
| Dawes/Fretzin Dermatology Group Inc | Indianapolis | Indiana | 46256 | — |
| Dermatology & Advanced Aesthetics | Lake Charles | Louisiana | 70605 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Central Dermatology | St Louis | Missouri | 63117 | — |
| UMDNJ Robert Wood Johnson | New Brunswick | New Jersey | 08901 | — |
| Wright State University | Dayton | Ohio | 45408 | — |
| Allergy, Asthma and Dermatology Research Center | Lake Oswego | Oregon | 97035 | — |
| Northwest Cutaneous Research Specialists | Portland | Oregon | 97210 | — |
| Oregon Med. Research Center, PC | Portland | Oregon | 97223 | — |
| Rivergate Dermatology Clinical Research | Goodlettsville | Tennessee | 37072 | — |
| Modern Research Associates | Dallas | Texas | 75231 | — |
| Dermatology Associates of Seattle | Seattle | Washington | 98101 | — |
| Aurora Advanced Healthcare, Inc | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00773734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2020 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00773734 live on ClinicalTrials.gov.